EMBL scientists receive prestigious ERC Starting Grant
Lab Matters Three EMBL scientists received this year’s ERC Starting Grants, and will be awarded €1.5 million over five years to carry out research projects.
2022
lab-matters
Common medications accumulate in gut bacteria
Science A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
science
New life science Imaging Centre preparing for user access
Lab Matters The EMBL Imaging Centre is preparing for external user access, after an on-time and on-budget build and handover to the science team.
2021
lab-matters
The power of community
Lab Matters EMBL Director Matthias Hentze describes the Environmental Research Initiative: a community effort to solve global environmental challenges.
2021
lab-matters
Michael Zimmermann receives FEBS Anniversary Prize
Lab Matters The Gesellschaft für Biochemie und Molekularbiologie has awarded a FEBS Anniversary Prize to Michael Zimmermann for his gut microbiome research.
2021
lab-matters
Welcome: Michael Zimmermann
Science Michael Zimmermann's group will investigate how gut microbes affect the body’s response to drugs.
2019
science
No matching posts found
